It's My Life
It's My Life It's My Life Hemophilia Village
Information for Health Care Professionals
Product Information Indication/Safety Information Tell a Friend Site Map
It's My Life

Home
About Hemophilia
Programs & Services
Treating Hemophilia
About BeneFIX
About ReFacto
Personal Stories
News & Resources
News
News Archive
Events Calendar
Online Resources
Publications
Wyeth & Hemophilia
Wyeth
News

 

Hemophilia Solutions - Special Issue

Welcome to a special issue of Hemophilia Solutions, soon to be incorporated into the Wyeth Lifelines newsletter. In this issue, we'll preview our activities at the National Hemophilia Foundation's (NHF) annual meeting in Dallas, Texas (November 4 - 6, 2004), and update you on the introduction of a new infusion system for ReFactoŽ Antihemophilic Factor (Recombinant) - the ReFacto R2 Kit.

ReFacto R2 Kit

The ReFacto R2 Kit - the first needle-less reconstitution device for hemophilia with a pre-filled diluent syringe - received approval by the U.S. Food and Drug Administration on September 10, 2004. Compared with the previous method for reconstituting ReFacto, the R2 kit provides a faster and simpler infusion process (R2 stands for Rapid Reconstitution).

If you are attending the NHF annual meeting, please stop by our booth for a demonstration of the ReFacto R2 Kit. Here's how it works:

  • The R2 kit contains a syringe prefilled with diluent, a vial adapter, and a single-use vial of ReFacto containing either 250, 500, 1000, or 2000 IUs.
  • The adapter is placed on the vial of ReFacto, and the adapter and prefilled syringe allow ReFacto to be reconstituted without the risk of needle exposure.

Wyeth will begin shipping the ReFacto R2 Kit to homecare companies and hemophilia treatment centers in the 4th quarter of 2004.

NHF Annual Meeting -- Preview

Bob -- Live and In Person!
Stop by the Wyeth booth (#400) and have your picture taken with Bob, a life-size version of the puppet used as a teaching tool in many hemophilia treatment centers around the country. Bob is part of the Wyeth Puppets as Teachers in Hemophilia (PATH) program, and is making his first appearance at the NHF Annual Meeting in Dallas.

The booth will also feature a theatrical play, projected with holograms, that tells the story of Bob's educational work in the hemophilia community. You won't want to miss this exciting show.

Ice Cream Social, Thursday, November 4
Wyeth is hosting an ice cream social on Thursday, November 4, from 8:30 pm - 11:30 pm at the Lookout Room of the observation level in Reunion Tower. Please stop by for ice cream, dessert and a great view of Dallas.

Educational Symposium, Friday, November 5
Wyeth is hosting an educational symposium "Living with Hemophilia: Challenges in Day-to-Day Life" on Friday, November 5 from 7:00 am - 9:00 am. Please join us for breakfast and the symposium. Breakfast is served at 6:30 am.

Other Activities at NHF
Wyeth is proud to be a Platinum sponsor of the NHF Annual Meeting, and is funding a variety of activities including:

  • Prevention and Treatment of Early Joint Disease in Hemophilia, Thursday, November 4, 10:15 am - 12:00 pm
  • Summer Camps Preconference: Developing the Ideal Summer Bleeding Disorders Camp, Thursday, November 4, 2:00 pm - 5:00 pm
  • Ports/Prophylaxis/Options, Saturday, November 5, 11:30 am - 1:00 pm
  • Life Without Training Wheels: Planning the Moves Toward Independence, Saturday, November 6, 12:00 - 1:00 pm

About ReFacto
ReFacto is indicated for the control and prevention of hemorrhagic episodes and for surgical and short-term routine prophylaxis in patients with hemophilia A. The effect of regular routine prophylaxis on long-term morbidity and mortality is unknown.

As with the intravenous administration of any protein product, adverse reactions may include headache, fever, chills, flushing, nausea, vomiting, tiredness, or symptoms of allergic reactions. The remote possibility exists for hypersensitivity to non-human mammalian proteins. Please see Prescribing Information.

We hope to see you in Dallas at the NHF Annual Meeting!

Back to News



   
Privacy Policy | Terms and Conditions
The information on this site is only intended for residents of the United States.
© 2007, Wyeth Pharmaceuticals Inc., Philadelphia, PA 19101
119533-01